Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
To assess the efficacy and safety of an optimised dosing regimen of rhTPO\'s prophylactic treatment of cancer treatment-induced thrombocytopenia(CTIT) and to explore the cardioprotective effect of rhTPO in cancer patients with high risk of treatment-induced cardiac injury.
Epistemonikos ID: ca645a6cf863a1e34a806ed4ab59536940f8de6b
First added on: May 13, 2024